Two new Ebola vaccine candidates will be added to a clinical trial in the Democratic Republic of the Congo (DRC) as the country continues to battle a deadly outbreak caused by the Bundibugyo species of the virus. Source: UN News
Your email address will not be published. Required fields are marked *
Name*
Email*
Website
Save my name, email, and website in this browser for the next time I comment.
Δ
© 2024 Egerin. All rights reserved.